453 related articles for article (PubMed ID: 25951995)
1. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
2. Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.
Sivapatham R; Zeng X
Methods Mol Biol; 2016; 1353():25-44. PubMed ID: 25520284
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells.
Lee HK; Morin P; Wells J; Hanlon EB; Xia W
Stem Cell Res; 2015 Sep; 15(2):325-7. PubMed ID: 26246272
[TBL] [Abstract][Full Text] [Related]
4. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
[TBL] [Abstract][Full Text] [Related]
5. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
7. Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus.
Soares FA; Pedersen RA; Vallier L
Methods Mol Biol; 2016; 1357():23-31. PubMed ID: 25687300
[TBL] [Abstract][Full Text] [Related]
8. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
[TBL] [Abstract][Full Text] [Related]
9. iPSCs-based generation of vascular cells: reprogramming approaches and applications.
Klein D
Cell Mol Life Sci; 2018 Apr; 75(8):1411-1433. PubMed ID: 29243171
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
[TBL] [Abstract][Full Text] [Related]
11. Generation of human induced pluripotent stem cells from cord blood cells.
Nishishita N; Takenaka C; Fusaki N; Kawamata S
J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
13. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.
Tucker BA; Anfinson KR; Mullins RF; Stone EM; Young MJ
Stem Cells Transl Med; 2013 Jan; 2(1):16-24. PubMed ID: 23283489
[TBL] [Abstract][Full Text] [Related]
14. Efficient induction of pluripotent stem cells from menstrual blood.
Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.
Seki T; Yuasa S; Oda M; Egashira T; Yae K; Kusumoto D; Nakata H; Tohyama S; Hashimoto H; Kodaira M; Okada Y; Seimiya H; Fusaki N; Hasegawa M; Fukuda K
Cell Stem Cell; 2010 Jul; 7(1):11-4. PubMed ID: 20621043
[No Abstract] [Full Text] [Related]
16. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
17. Skin Biopsy and Patient-Specific Stem Cell Lines.
Li Y; Nguyen HV; Tsang SH
Methods Mol Biol; 2016; 1353():77-88. PubMed ID: 26141312
[TBL] [Abstract][Full Text] [Related]
18. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.
Jin ZB; Okamoto S; Xiang P; Takahashi M
Stem Cells Transl Med; 2012 Jun; 1(6):503-9. PubMed ID: 23197854
[TBL] [Abstract][Full Text] [Related]
19. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.
Merling RK; Sweeney CL; Choi U; De Ravin SS; Myers TG; Otaizo-Carrasquero F; Pan J; Linton G; Chen L; Koontz S; Theobald NL; Malech HL
Blood; 2013 Apr; 121(14):e98-107. PubMed ID: 23386128
[TBL] [Abstract][Full Text] [Related]
20. Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells.
Shoji E; Woltjen K; Sakurai H
Methods Mol Biol; 2016; 1353():89-99. PubMed ID: 25971915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]